The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells
Abstract
Beyond its antidiabetic activity justifying its use in the treatment of the type 2 diabetes, metformin (MET [dimethylguanidine, Glucophage]) has been shown to exhibit antioxidant properties in vitro, which could contribute to limit the deleterious vascular complications of diabetes. We investigated whether MET, at the pharmacological level of 10 -5 mol/L, was able to modulate intracellular production of reactive oxygen species (ROS) both in quiescent bovine aortic endothelial cells (BAECs) and in BAECs stimulated by a short incubation with high levels of glucose (30 mmol/L, 2 hours) or angiotensin II (10 -7 mol/L, 1 hour). Intracellular ROS production was measured by fluorescence of the DCF (2,7-dichlorodihydrofluorescein) probe. Our results showed that MET was able to reduce the intracellular production of ROS in both nonstimulated BAECs (-20%, P < .05) and BAEC stimulated by high levels of glucose or angiotensin II (-28% and -72%, respectively, P < .01). Experiments performed in the presence of the nicotinamide adenine dinucleotide phosphate [NAD(P)H] oxidase inhibitor apocynin or the respiratory mitochondrial chain inhibitor rotenone indicated that MET exerted its effect partly through an inhibition of the formation of ROS produced mainly by NAD(P)H oxidase and also, to a lesser extent, by the respiratory mitochondrial chain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Metformin and other drugs used for T2DM, like the SGLT2 inhibitors, may also reduce hyperglycemia-induced elevated endothelial ROS, independent of negative effects on complex 1, such as via inhibition of NADPH oxidase or blocking the entry of glucose into the endothelium (32, 107–109, 187, 188)”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [107]
Citations
Cites
1 retracted
Activation of the AMP-activated Protein Kinase by the Anti-diabetic Drug Metformin in Vivo
Zou, M., Kirkpatrick, S. S., Davis, B. J., Nelson, J. S., Wiles, W. G., Schlattner, U., Neumann, D., Brownlee, M., Freeman, M. B., & Goldman, M. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404421200 · Cited by 480
RetractedRole of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Halliwell, B., & Whiteman, M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705776 · Cited by 2,238
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Inoguchi, T., Li, P., Umeda, F., Yu, H. Y., Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1939 · Cited by 1,577
The role of oxidized lipoproteins in atherogenesis
Berliner, J. A., & Heinecke, J. W. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02173-6 · Cited by 1,369
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y., Pinsky, D. J., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,305
Role of oxidative stress in atherosclerosis
Harrison, D., Griendling, K. K., Landmesser, U., Hornig, B., & Drexler, H. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03144-2 · Cited by 1,275
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084
Musi, N., Hirshman, M. F., Nygren, J., Svanfeldt, M., Bavenholm, P., Rooyackers, O., Zhou, G., Williamson, J. M., Ljunqvist, O., Efendic, S., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2074 · Cited by 806
Angiotensin II Stimulation of NAD(P)H Oxidase Activity
Seshiah, P., Weber, D. S., Ročić, P., Valppu, L., Taniyama, Y., & Griendling, K. K. (2002) · Circulation Research · doi:10.1161/01.res.0000033523.08033.16 · Cited by 711
Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells
Carter, W. O., Narayanan, P. K., & Robinson, J. P. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.55.2.253 · Cited by 640
How hyperglycemia promotes atherosclerosis: molecular mechanisms
Aronson, D., & Rayfield, E. J. (2002) · Cardiovascular Diabetology · doi:10.1186/1475-2840-1-1 · Cited by 520
Johnson, J. A., Majumdar, S. R., Simpson, S. H., & Toth, E. L. (2002) · Diabetes Care · doi:10.2337/diacare.25.12.2244 · Cited by 421
The Antihyperglycaemic Effect of Metformin
Wiernsperger, N. F., & Bailey, C. J. (1999) · Drugs · doi:10.2165/00003495-199958001-00009 · Cited by 320
Mechanism of Endothelial Cell NADPH Oxidase Activation by Angiotensin II
Li, J., & Shah, A. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209793200 · Cited by 307
Zhang, H. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00183-2 · Cited by 296
Oxidation pathways for the intracellular probe 2′,7′-dichlorofluorescin
Zhu, H., Bannenberg, G. L., Moldéus, P., & Shertzer, H. G. (1994) · Archives of Toxicology · doi:10.1007/s002040050118 · Cited by 261
Rueckschloss, U., Quinn, M. T., Holtz, J., & Morawietz, H. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000035392.38687.65 · Cited by 216
Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy.
Ceriello, A., Morocutti, A., Mercuri, F., Quagliaro, L., Moro, M., Damante, G., & Viberti, G. C. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2170 · Cited by 209
Cai, H. “., Li, Z., Dikalov, S., Holland, S. M., Hwang, J., Jo, H., Dudley, S. C., & Harrison, D. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208884200 · Cited by 182
Oxidative stress in cardiovascular disease: myth or fact?
Ceconi, C., Boraso, A., Cargnoni, A., & Ferrari, R. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.06.002 · Cited by 170
Faure, P., Rossini, E., Wiernsperger, N., Richard, M. J., Favier, A., & Halimi, S. (1999) · Diabetes · doi:10.2337/diabetes.48.2.353 · Cited by 166
Tampo, Y., Kotamraju, S., Chitambar, C. R., Kalivendi, S. V., Keszler, Á., Joseph, J., & Kalyanaraman, B. (2003) · Circulation Research · doi:10.1161/01.res.0000048195.15637.ac · Cited by 164
Bonnefont‐Rousselot, D., Raji, B., Walrand, S., Gardès-Albert, M., Jore, D., Legrand, A., Peynet, J., & Vasson, M. (2003) · Metabolism · doi:10.1053/meta.2003.50093 · Cited by 162
Abbasi, F., Chu, J. W., McLaughlin, T., Lamendola, C. A., Leary, E. T., & Reaven, G. M. (2004) · Metabolism · doi:10.1016/j.metabol.2003.07.020 · Cited by 162
Balzer, M. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00025-5 · Cited by 152
Vascular targets of redox signalling in diabetes mellitus
Spitaler, M. M., & Graier, W. F. (2002) · Diabetologia · doi:10.1007/s00125-002-0782-0 · Cited by 149
Mitochondrial metabolism and type-2 diabetes: a specific target of metformin
Leverve, X. M., Guigas, B., Détaille, D., Batandier, C., Koceir, E.-A., Chauvin, C., Fontaine, E. M., & Wiernsperger, N. F. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(03)72792-x · Cited by 132
Senescence-associated cell death of human endothelial cells: the role of oxidative stress
Unterluggauer, H. (2003) · Experimental Gerontology · doi:10.1016/j.exger.2003.08.007 · Cited by 121
Hayden, M. R., & Tyagi, S. C. (2002) · Cardiovascular Diabetology · doi:10.1186/1475-2840-1-3 · Cited by 115
Pavlovic, D. D., Kocić, R., Kocic, G. M., Jevtović, T., Radenković, S., Mikić, D., Stojanović, M., & Djordjević, P. (2000) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00089.x · Cited by 113
Martı́n, C., Martı́nez, R., Navarro, R., Ruiz-Sanz, J. I., Lacort, M., & Ruiz‐Larrea, M. B. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00704-3 · Cited by 112
Brubacher, J. L., & Bols, N. C. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(01)00308-8 · Cited by 102
Asahina, T., Kashiwagi, A., Nishio, Y., Ikebuchi, M., Harada, N., Tanaka, Y., Takagi, Y., Saeki, Y., Kikkawa, R., & Shigeta, Y. (1995) · Diabetes · doi:10.2337/diab.44.5.520 · Cited by 102
Détaille, D., Guigas, B., Leverve, X. M., Wiernsperger, N. F., & Devos, P. E. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00858-4 · Cited by 100
Effect of metformin on glutathione and magnesium in normal and streptozotocin‐induced diabetic rats
Ewis, S. A., & Abdel‐Rahman, M. S. (1995) · Journal of Applied Toxicology · doi:10.1002/jat.2550150508 · Cited by 98
Dominguez, L. J., Davidoff, A. J., Srinivas, P. R., Standley, P. R., Walsh, M. F., & Sowers, J. R. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536601 · Cited by 87 · cited 1×
“To exert its antihyperglycemic effect, MET was shown to enhance cellular insulin signaling, in part by enhancing the decrease in cyclic (c)AMP levels induced by insulin [46], by increasing tyrosine kinase activity [47,48], as well as by decreasing tyrosine phosphatase activity [49], in relation to the modulation of ce…”
BackgroundYano, M., Hasegawa, G., Ishii, M., Yamasaki, M., Fukui, M., Nakamura, N., & Yoshikawa, T. (2004) · Redox Report · doi:10.1179/135100004225004779 · Cited by 85
Tessier, D., Maheux, P., Khalil, A., & Fülöp, T. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90226-3 · Cited by 84
Valgimigli, M., Merli, E., Malagutti, P., Soukhomovskaia, O., Cicchitelli, G., Macrı̀, G., & Ferrari, R. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.07.006 · Cited by 82
Kashiwagi, A., Asahina, T., Nishio, Y., Ikebuchi, M., Tanaka, Y., Kikkawa, R., & Shigeta, Y. (1996) · Diabetes · doi:10.2337/diab.45.3.s84 · Cited by 82
Microcirculation in insulin resistance and diabetes: more than just a complication
Wiernsperger, N. F., & Bouskela, E. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(03)72791-8 · Cited by 68
Antidiabetic and antimalarial biguanide drugs are metal-interactive antiproteolytic agents
Sweeney, D., Raymer, M. L., & Lockwood, T. D. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00338-1 · Cited by 66
Holland, W. L., Morrison, T. E., Chang, Y., Wiernsperger, N., & Stith, B. J. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.02.016 · Cited by 57
Monotherapy with Metformin: Does It Improve Hypoxia in Type 2 Diabetic Patients?
Ćosić, V., Antić, S., Pesić, M., Jovanović, O., Kundalić, S., & Djordjević, V. B. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.135 · Cited by 38
Asahina, T., Kashiwagi, A., Nishio, Y., et al. (1995) · Diabetes · doi:10.2337/diabetes.44.5.520 · Cited by 37
Rappeneau, S. (2000) · Toxicological Sciences · doi:10.1093/toxsci/54.1.212 · Cited by 33
Rappeneau, S., Baeza‐Squiban, A., Braut‐Boucher, F., Aubery, M., Gendron, M. C., & Marano, F. (1999) · Toxicology in Vitro · doi:10.1016/s0887-2333(99)00042-9 · Cited by 14
Cellular mechanism of metformin action.
Grigorescu, F., Laurent, A., Chavanieu, A., & Capony, J. (1991) · PubMed · Cited by 13
Détaille, D., Wiernsperger, N. F., & Devos, P. (1998) · Diabetologia · doi:10.1007/s001250050859 · Cited by 12
Détaille, D., Wiernsperger, N. F., & Devos, P. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00222-1 · Cited by 11
Research works printed but not linked: 1
- Martin, 2001, tert-Butyl hydroperoxide–induced lipid signaling in hepatocytes: involvement of glutathione and free radicals, Biochem Pharmacol, 62, 705
Cited by
Sorted by citations
Cellular and molecular mechanisms of metformin: an overview
Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720
Metformin: from mechanisms of action to therapies
Foretz, M., Guigas, B., Bertrand, L., Pollak, M., & Viollet, B. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.018 · Cited by 1,501
A review on the role of antioxidants in the management of diabetes and its complications
Rahimi, R., Nikfar, S., Larijani, B. A., & Abdollahi, M. R. (2005) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2005.07.002 · Cited by 890
Molecular mechanism of action of metformin: old or new insights?
Rena, G., Pearson, E. R., & Sakamoto, K. (2013) · Diabetologia · doi:10.1007/s00125-013-2991-0 · Cited by 479
Metformin and inflammation: its potential Beyond glucose-lowering effect
Saisho, Y. (2015) · Endocrine, Metabolic & Immune Disorders-Drug Targets · doi:10.2174/1871530315666150316124019 · Cited by 450
Metadata
- Authors
- Ouslimani, N., Peynet, J., Bonnefont-Rousselot, D., Thérond, P., Legrand, A., & Beaudeux, J.-L.
- Corresponding author
- Beaudeux, Jean-Louis
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 54
- Issue
- 6
- Pages
- 829-834
- ISSN
- 0026-0495 (ISSN-L)
- OpenAlex
- W2103676852
- Cited by
- 204
- References
- 54
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 8 · 2023: 5 · 2022: 6 · 2021: 20 · 2020: 14 · 2019: 10 · 2018: 9 · 2017: 9 · 2016: 15 · 2015: 13 · 2014: 11 · 2013: 12 · 2012: 11
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- metformin, reactive oxygen species, aortic endothelial cells, antioxidant activity, NADPH oxidase, apocynin, mitochondrial respiratory chain, angiotensin II, high glucose, diabetic vascular complications, type 2 diabetes
- MeSH terms
- Animals, Aorta, Cattle, Cells, Cultured, Hypoglycemic Agents, Metformin, Reactive Oxygen Species, NADPH Oxidases, Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review